摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(1-氧代十六烷基)-L-脯氨酸 | 59441-32-6

中文名称
1-(1-氧代十六烷基)-L-脯氨酸
中文别名
N-十六烷基脯氨酸;棕榈酰脯氨酸;1-十六碳酰吡咯烷-2-甲酸
英文名称
N-palmitoyl-L-proline
英文别名
n-C15H31CO-Pro-OH;(S)-1-palmitoylpyrrolidine-2-carboxylic acid;N-palmitoylproline;1-(1-oxohexadecyl)-L-proline;palmitoylproline;(2S)-1-hexadecanoylpyrrolidine-2-carboxylic acid
1-(1-氧代十六烷基)-L-脯氨酸化学式
CAS
59441-32-6
化学式
C21H39NO3
mdl
——
分子量
353.546
InChiKey
XOAIXMQPJQVGRV-IBGZPJMESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    66-67 °C
  • 沸点:
    511.6±43.0 °C(Predicted)
  • 密度:
    0.997±0.06 g/cm3(Predicted)
  • LogP:
    7.394 (est)

计算性质

  • 辛醇/水分配系数(LogP):
    7.4
  • 重原子数:
    25
  • 可旋转键数:
    15
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    57.6
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090

SDS

SDS:f44f78b9d7f44981b0131dc9af0f8771
查看

上下游信息

反应信息

点击查看最新优质反应信息

文献信息

  • INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN WHEREIN THE PI IS COMPRISED FORM 5.8 TO 8.5 AND A CO-POLYAMINO ACID BEARING CARBOXYLATE CHARGES AND HYDROPHOBIC RADICALS
    申请人:ADOCIA
    公开号:US20190275115A1
    公开(公告)日:2019-09-12
    In one embodiment, the composition according to the invention is characterized in that the co-polyamino acid bearing carboxylate charges and at least one hydrophobic radical -Hy is chosen among the co-polyamino acids according to formula XXXb hereinafter: wherein, D represents, independently, either a group —CH 2 — (aspartic acid) or a group —CH 2 —CH 2 — (glutamic acid), X represents a cationic entity chosen in the group comprising alkali cations, R b and R b ′, identical or different, are either a hydrophobic radical -Hy, or a radical chosen in the group consisting of an H, a C2 to C10 linear acyl group, a C3 to C10 branched acyl group, a benzyl, a terminal “amino acid” unit and a pyroglutamate, at least one of Rb and R′b is a hydrophobic radical -Hy, Q and Hy are as defined above. n+m represents the degree of polymerization DP of the co-polyamino acid, namely the mean number of monomeric units per co-polyamino acid chain and 5≤n+m≤250.
    在一种实施例中,根据本发明的组合物的特征在于,共聚氨基酸带有羧酸盐基团和至少一种疏水基团-Hy,所述疏水基团-Hy是从下文公式XXXb中的共聚氨基酸中选择的: 其中, D分别表示一个基团—CH 2 —(天冬氨酸)或一个基团—CH 2 —CH 2 —(谷氨酸), X表示从包括碱金属阳离子在内的阳离子实体中选择的一个阳离子实体, R b 和R b ′,相同或不同,要么是一个疏水基团-Hy,要么是从包括H、C2到C10线性酰基团、C3到C10支链酰基团、苄基、末端“氨基酸”单元和吡咯谷氨酸在内的基团中选择的一个基团, Rb和R′b中至少一个是疏水基团-Hy, Q和Hy如上所定义。 n+m表示共聚氨基酸的聚合度DP,即每个共聚氨基酸链上的单体单位的平均数,且5≤n+m≤250。
  • Sun protection compositions comprising semi-crystalline polymers and hollow latex particles
    申请人:Candau Didier
    公开号:US20090041691A1
    公开(公告)日:2009-02-12
    Topically applicable cosmetic/dermatological UV protection compositions having enhanced SPF contain at least one organic UV screening agent and/or at least one inorganic screening agent, such compositions also containing at least the following constituents (A) and (B): A) a semi-crystalline polymer which is solid at ambient temperature and has a melting point of greater than or equal to 30° C., containing a) a polymeric backbone and b) at least one crystallizable organic side chain and/or one crystallizable organic block forming part of the backbone of this said polymer, said polymer having a number-average molecular mass Mn of greater than or equal to 1,000, and B) hollow latex particles having a particle size ranging from 150 to 380 nm, formulated into a topically applicable, physiologically acceptable medium therefor.
    具有增强SPF的适用于化妆品/皮肤科的防紫外线保护组合物至少包含一种有机紫外线过滤剂和/或至少一种无机过滤剂,此类组合物还至少包含以下成分(A)和(B): A)半结晶聚合物,室温下为固体,熔点大于或等于30°C,包含a)聚合骨架和b)至少一种可结晶有机侧链和/或作为该聚合物骨架一部分的可结晶有机块,该聚合物具有大于或等于1,000的数均分子质量Mn,以及 B)中空乳胶颗粒,粒径范围为150至380纳米,配制成适用于局部使用的、生理上可接受的介质。
  • Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid
    申请人:ADOCIA
    公开号:US20170348395A1
    公开(公告)日:2017-12-07
    An injectable aqueous solution, the pH of which is from 6.0 to 8.0, having at least: a) human glucagon, and b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy. In an embodiment, the compositions have, in addition, a gastrointestinal hormone.
    一个可注射的水溶液,其pH值在6.0到8.0之间,至少含有:a) 人类胰高血糖素,和b) 一个带有羧基电荷和疏水基团的共聚氨基酸Hy。在一种实施例中,该组合物还含有一个胃肠激素。
  • COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG, AND A CO-POLYAMINO ACID
    申请人:ADOCIA
    公开号:US20180193421A1
    公开(公告)日:2018-07-12
    An injectable aqueous solution, of which the pH is from 6.0 to 8.0, comprising at least: a) amylin, an amylin receptor agonist or an amylin analog; b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, said co-polyamino acid consisting of glutamic or aspartic units and said hydrophobic radicals Hy having the following formula I: GpR r GpA a GpC) p I wherein the composition does not comprise a basal insulin of which the isoelectric point pI is from 5.8 to 8.5. It also relates to a composition wherein it moreover comprises a prandial insulin.
    一种可注射的水溶液,其pH值为6.0至8.0,包括至少:a) 组氨酸、组氨酸受体激动剂或组氨酸类似物;b) 具有羧基带电荷和疏水基团Hy的共聚氨基酸,所述共聚氨基酸由谷氨酸或天冬氨酸单元组成,所述疏水基团Hy具有以下公式I:GpRrGpAaGpC)pI其中该组成不包括等电点pI为5.8至8.5的基础胰岛素。还涉及一种组成物,其中还包括一种餐后胰岛素。
  • [EN] COMPOUNDS USEFUL IN THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS, AND/OR MUCOUS MEMBRANES<br/>[FR] COMPOSÉS UTILES DANS LE TRAITEMENT ET/OU LE SOIN DE LA PEAU, DES CHEVEUX, DES ONGLES ET/OU DES MEMBRANES MUQUEUSES
    申请人:LUBRIZOL ADVANCED MAT INC
    公开号:WO2017100421A1
    公开(公告)日:2017-06-15
    Compounds of general formula (I): R1-Wm-Xn-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2 (I) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, cosmetic and/or pharmaceutical compositions which contain them and their use in medicine, and in processes of treatment and/or care of the skin, hair and/or mucous membranes, in particular in the aging and photoaging of the skin.
    通式(I)的化合物:R1-Wm-Xn-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2(I),它们的立体异构体、混合物和/或其在化妆品或药用上可接受的盐,含有它们的化妆品和/或药用组合物,以及它们在医学中的使用,以及在皮肤、头发和/或黏膜的治疗和/或护理过程中的使用,特别是在皮肤的衰老和光老化方面。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物